Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting
PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial